Table 2.
Baseline to follow-up measures
| Baseline | T1: 3 weeks | T2: 6 weeks | T3: 12 weeks | T4: 6 months | |
|---|---|---|---|---|---|
| Inclusion/exclusion criteria |
X |
|
|
|
|
| Demographic data |
X |
|
|
|
|
| GPE |
|
X |
X |
X |
X |
| SPS |
X |
X |
X |
X |
X |
| SDQ-NL |
X |
X |
X |
X |
X |
| SPADI |
X |
X |
X |
X |
X |
| EQ5D |
X |
X |
X |
X |
X |
| WAV-12 |
|
|
X |
|
|
| Medical consumption |
X |
|
X |
X |
X |
|
Physiotherapist | |||||
| Interpretation from physical examination and patient history |
X |
|
|
|
|
| Change in treatment plan |
X |
X |
X |
X |
|
| Treatment goals |
X |
X |
X |
X |
|
| Number of treatments | X | X | X | X | |
GPE: General Perceived Effect, SPS: Shoulder Pain Score, SDQ-NL: Dutch Shoulder Disability Questionnaire, SPADI: Shoulder Pain and Disability Index, EQ5D: Euroquol five-item quality of life questionnaire, WAV-12: Dutch Working Alliance Scale (Short Form).